文献速递头颈甲状腺与浅表介入USCT

超声引导下射频消融治疗甲状腺半切除术后中央区复发肿瘤的疗效

Treatment Efficacy of Radiofrequency Ablation for Recurrent Tumor at the Central Compartment After Hemithyroidectomy.
PubMed 文献 · AJR Am J Roentgenol · 2021-03-31

回顾性分析8例患者共10个半甲状腺切除术后中央区复发肿瘤,行超声引导下射频消融,平均肿瘤体积缩小率97.8%±7.0%,10个肿瘤均达完全消融,9个经超声或CT确认完全消失,随访33.0个月无复发,无严重并发症。

要点

  • 中央区复发肿瘤射频消融后体积缩小率可达97.8%±7.0%。
  • 完全消融率100%,随访33.0个月无复发证据。
  • 术后需超声随访并建议增强CT评估消融效果。

关键影像表现/征象

  • 随访超声计算肿瘤体积缩小率(VRR),公式为(初始体积-最终体积)×100/初始体积。
  • 完全肿瘤消失定义为随访超声或CT上无可见的治疗后肿瘤。
  • 9个复发肿瘤确认完全消失,1个超声显示VRR 77.8%但CT无强化。

诊断标准与关键数值

  • 平均肿瘤VRR为97.8%±7.0%(标准差),范围77.8-100%。
  • 完全消融定义为10个复发肿瘤均达到完全消融。
  • 完全消失标准为随访超声或CT无可见治疗肿瘤,9个肿瘤符合。

临床应用与阅片要点

  • 射频消融可作为半甲状腺切除术后中央区复发肿瘤的微创治疗选择。
  • 术后应规律超声随访,必要时增强CT确认无强化残留。

局限性

  • 回顾性研究,样本量小(8例患者10个肿瘤)。
  • 单中心研究,随访时间有限(平均33.0个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The aim of this study was to evaluate the efficacy of ultrasound (US)-guided radiofrequency ablation (RFA) for recurrent tumor in the central compartment after hemithyroidectomy. MATERIALS AND METHODS. The medical records of patients who underwent RFA for recurrent tumor after hemithyroidectomy between January 2008 and December 2018 were reviewed. Eight patients who underwent RFA for 10 recurrent tumors after hemithyroidectomy were included in our study population. Patients underwent follow-up US 1, 6, and 12 months after treatment and annually thereafter. The tumor volume reduction rate (VRR) was calculated as follows: VRR = ([initial volume - final volume] × 100) / initial volume. All patients were advised to undergo contrast-enhanced CT after tumor ablation. Complete tumor disappearance was defined as no visible treated tumor on follow-up US or CT. RESULTS. Mean tumor VRR was 97.8% ± 7.0% (SD) (range, 77.8-100%). Complete tumor ablation was achieved for all 10 recurrent tumors. Complete disappearance was confirmed in nine recurrent tumors, and one recurrent tumor showed a VRR of 77.8% on US but there was no enhancement on CT. All eight patients achieved no evidence of disease during mean follow-up of 33.0 months. RFA was tolerated by all patients; there were no major complications or procedure-related deaths. One patient experienced transient voice change during RFA. CONCLUSION. RFA can be considered to be an effective and safe alternative treatment method for recurrent tumor in the central compartment after hemithyroidectomy.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Chung SR, Baek JH, Choi YJ, et al. Treatment Efficacy of Radiofrequency Ablation for Recurrent Tumor at the Central Compartment After Hemithyroidectomy. AJR Am J Roentgenol. 2021. PMID: 33787293. doi:10.2214/AJR.20.23434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。